1.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: GTI-0115, NCI-V96-0990
|
|
2.
|
Phase: Phase III Type: Supportive care Status: Completed Age: 16 and over Sponsor: NCI, Other Protocol IDs: 1577.00, FHCRC-1577.00, MSKCC-01127, NCI-H01-0072, NCT00016068
|
|
3.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: over 18 Sponsor: Other Protocol IDs: UCMC-95-3-20-2, NCI-V95-0681
|
|
4.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: UCMC-95-3-20-1, NCI-V95-0682
|
|
5.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 3 to 21 Sponsor: Pharmaceutical / Industry Protocol IDs: GTI-0106, NCI-V96-0989
|
|
6.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: NINDS Protocol IDs: NINDS-92-N-0246
|
|
7.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: HGTRI-0105, NCI-V00-1584, NCT00005025
|
|
8.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000068204, AMC-019, NCT00006264
|
|
9.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-05-C-0203, NCI-P6330, NCT00217503
|
|
10.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: 98074, P30CA033572, CHNMC-98074, CDR0000564546, NCT00530218
|
|
11.
|
Phase: Phase I Type: Treatment Status: Closed Age: 18 to 45 Sponsor: NCI Protocol IDs: FHCRC-696.2, NCI-H94-0411
|
|
12.
|
Phase: Phase I Type: Treatment Status: Completed Age: 3 and over Sponsor: Other Protocol IDs: BUMC-3756, BUSM-FDR001532, NCI-V00-1609, NCT00006340
|
|
13.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000065004, UPCC-3394, NCI-H96-0976, NCT00002824
|
|
14.
|
Phase: Phase I Type: Treatment Status: Closed Age: 2 to 18 Sponsor: Pharmaceutical / Industry Protocol IDs: GTI-0104, NCI-V96-0988
|
|
15.
|
Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: MGH-H97-1122, NCI-H97-1122
|
|
16.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: HGTRI-0101, NCI-V97-1177
|
|
17.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-98-C-0140C, NCT00005057
|
|
18.
|
Phase: Phase I Type: Treatment Status: Closed Age: Not specified Sponsor: Other Protocol IDs: LSUMC-3591, NCI-V00-1604, NCT00006216
|
|
19.
|
Phase: Phase I Type: Supportive care, Treatment Status: Completed Age: 1 to 17 Sponsor: NCI, Other Protocol IDs: 1524.00, FHCRC-1524.00, NCI-H00-0065, CDR0000068310, NCT00006480
|
|
20.
|
Phase: No phase specified Type: Supportive care Status: Completed Age: any age Sponsor: Protocol IDs: MSKCC-92118A1, NCI-V93-0251
|
|
21.
|
Phase: No phase specified Type: Supportive care, Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: 99061, R01AI058148, P30CA033572, CHNMC-99061, CDR0000600022, NCT00716911
|
|
22.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Supportive care Status: Temporarily closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: 09038, NCI-2010-01932, NCT01199562
|